Dapa Vilda 5/100SR Tablets provide an established, clinically unified combination anti-hyperglycemic therapy carefully developed for the continuous management, long-term stabilization, and comprehensive metabolic protection of Type 2 Diabetes Mellitus. Achieving tight glycemic targets often requires addressing independent physiological errors simultaneously—specifically renal glucose over-reabsorption and progressive pancreatic beta-cell dysfunction. This advanced formulation seamlessly integrates a filtration-driven gliflozin with a glucose-dependent gliptin within a unified unit, optimizing glycemic clearance paths without putting undue stress on pancreatic reserves safely over a long-term care routine.
The synchronized formulation operates dynamically across two distinct metabolic fronts:
-
Dapagliflozin (5 mg): A highly selective sodium-glucose co-transporter 2 (SGLT2) inhibitor that works entirely independently of insulin pathways. By blocking SGLT2 transport networks in the proximal convoluted tubules of the kidneys, it stops sugar from re-entering the bloodstream, actively filtering excess glucose out via the urine. This process also encourages a gentle osmotic fluid reduction to unload cardiovascular strain.
-
Vildagliptin (100 mg SR): A potent dipeptidyl peptidase-4 (DPP-4) inhibitor embedded in a specialized sustained-release matrix layout. By selectively locking the DPP-4 enzyme, it extends the biological lifespan of natural incretin hormones (GLP-1 and GIP). These hormones signal the pancreas to release more insulin and suppress excess liver glucagon production—but strictly in a glucose-dependent loop, significantly dropping tracking risks of sudden blood sugar crashes.
Key Benefits
-
Advanced Dual-Action Synthesis: Combines an insulin-independent kidney filter with an incretin-driven pancreatic response for complete blood sugar defense.
-
Sustained-Release Optimization: Vildagliptin core releases evenly over 24 hours, stabilizing glycemic fluctuations smoothly between and after meals.
-
Low Risk of Hypoglycemia: Pancreatic stimulation triggers only when blood glucose levels are high, preserving exceptionally safe physiological boundaries.
-
Secondary Cardio-Renal Benefits: Helps reduce baseline blood pressure profiles and decreases high intra-glomerular pressure inside delicate kidney filters.
-
Trusted Quality Execution: Manufactured under strict pharmaceutical guidelines of Steris, ensuring uniform micro-dose distribution and reliable ingredient bioavailability.
Directions for Use
-
Take exactly as directed by your diabetologist, endocrinologist, or primary healthcare physician.
-
Dapa Vilda 5/100SR is strictly taken orally once daily, at the exact same hour every single morning, with or immediately after your breakfast.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, split, or chew it, as doing so will instantly destroy the specialized sustained-release framework and cause rapid medicine dumping.
-
Mandatory Daily Hydration Track: Because this medicine channels glucose through your urinary tract, you must consciously maintain a generous intake of water throughout the day to prevent systemic dehydration.
Safety & Precautions
-
Do not alter your dose or stop taking this medication suddenly without explicit professional direction, as blood sugar levels can rise rapidly behind risk lines.
-
Genital & Urinary Tract Hygiene Rule: Increased sugar concentrations in the urine create a natural environment for microbial tracking. Maintain strict personal hygiene and contact your doctor immediately if you notice persistent burning during urination, localized redness, or itching.
-
Euglycemic DKA Warning: SGLT2 inhibitors can occasionally trigger a serious condition called Diabetic Ketoacidosis (DKA) even when blood sugar levels look completely normal or near-normal. Seek immediate medical triage if you experience severe nausea, continuous vomiting, rapid deep breathing, confusion, or sudden extreme lethargy.
-
Inform your specialist before initialization if you track a prior clinical history of liver enzyme flaring, severe pancreatic inflammation (pancreatitis), or advanced kidney filtration decline.
-
Monitor your renal function profiles (serum creatinine / eGFR) and liver function parameters (LFTs) regularly during long-term chronic routines.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Always keep the tablets safely sealed inside their original protective blister packaging layout until the exact moment of intake to shield the core components from ambient humidity.
